Ebrahimi, F.; Zargari, N.R.; Akhlaghi, M.; Asghari, S.M.; Abdi, K.; Balalaie, S.; Asadi, M.; Beiki, D.
Synthesis, Radiolabeling, and Biodistribution Study of a Novel DOTA-Peptide for Targeting Vascular Endothelial Growth Factor Receptors in the Molecular Imaging of Breast Cancer. Pharmaceutics 2024, 16, 899.
https://doi.org/10.3390/pharmaceutics16070899
AMA Style
Ebrahimi F, Zargari NR, Akhlaghi M, Asghari SM, Abdi K, Balalaie S, Asadi M, Beiki D.
Synthesis, Radiolabeling, and Biodistribution Study of a Novel DOTA-Peptide for Targeting Vascular Endothelial Growth Factor Receptors in the Molecular Imaging of Breast Cancer. Pharmaceutics. 2024; 16(7):899.
https://doi.org/10.3390/pharmaceutics16070899
Chicago/Turabian Style
Ebrahimi, Fatemeh, Nooshin Reisi Zargari, Mehdi Akhlaghi, S. Mohsen Asghari, Khosrou Abdi, Saeed Balalaie, Mahboobeh Asadi, and Davood Beiki.
2024. "Synthesis, Radiolabeling, and Biodistribution Study of a Novel DOTA-Peptide for Targeting Vascular Endothelial Growth Factor Receptors in the Molecular Imaging of Breast Cancer" Pharmaceutics 16, no. 7: 899.
https://doi.org/10.3390/pharmaceutics16070899
APA Style
Ebrahimi, F., Zargari, N. R., Akhlaghi, M., Asghari, S. M., Abdi, K., Balalaie, S., Asadi, M., & Beiki, D.
(2024). Synthesis, Radiolabeling, and Biodistribution Study of a Novel DOTA-Peptide for Targeting Vascular Endothelial Growth Factor Receptors in the Molecular Imaging of Breast Cancer. Pharmaceutics, 16(7), 899.
https://doi.org/10.3390/pharmaceutics16070899
